Table Of Content

AUTHOR INDEX Abe, H. ‘NMDA induces PKC translocation 287 See Ushio, Y. Evangelista, S. and Maggi, C.A. Abe, K., Iri, Y., Takayanagi, M. and Saito, H. Sialoadenectomy and capsaicin 377 bFGF’s trophic action and protein kinase 563 Abe, K., Takayanagi, M. and Saito, H. Fujimoto, M. bFGF and EGF as neurotrophic factors 113 See Mihara, S. Aisaka, K., Mitani, A., Kitajima, Y., Ohno, T. Fujimura, A., Kajiyama, H., Ohashi, K. and Ishihara, T. and Ebihara, A. Pressor effect of L-NMMA in rats 245 Chronopharmacology of S-8666 43 Aizu, E. Fujimura, A., Kajiyama, H., Shiga, T., Ohashi, K. See Nakadate, T. and Ebihara, A. Akahane, K. Chronopharmacology of nitrendipine 237 See Saegusa, K. Fujimura, A., Ohashi, K. and Ebihara, A. Akimoto, T. Chronopharmacology of S-8666 105 See Ichida, S. Li and urinary furosemide excretion 421 Amano, H. Fujisue, T. See Ito, Hitoshi See Ichida, S. Amemiya, N. Fujiwara, M. See Hatta, S. See Ebii, K. Aoki, S. Fukunaga, R. See Kurahashi, K. See Ebii, K. Arai, M. Furukawa, Y. See Togari, A. See Saegusa, K. Ariyoshi, S. Furusawa, K. See Ichida, S. Drug effects on cognitive function in mice 483 Asashi, T. See Kuribara, H. Gaggi, R. and Gianni, A.M. Calcium antagonists and brain amines 33 Baba, A. Gianni, A.M. See Etoh, S. See Gaggi, R. Baba, S. Goto, A. See Tsuchihashi, H. See Yoshimoto, R. Goto, Shinichiro, Egashira, T. and Yamanaka, Y. Chiba, S. Serotonin uptake inhibitors in CSF 297 See Saegusa, K. Goto, Shoichi See Nagai, H. Dohi, T. See Yoshimura, Y. Handa, J. Dohmoto, H. See Takakura, S. See Yoshimoto, R. Haniuda, M. See Saegusa, K. Ebihara, A. Harada, M. See Fujimura, A. See Takayanagi, I. Ebii, K., Fukunaga, R., Taniguchi, T., Fujiwara, M.., Hashida, R. Nakayama, S., Saitoh, Yuichi and Kimura, Y. See Saeki, T. Carteolol and £-receptors in SHR heart 505 Hashimoto, K. Egashira, T. See Sugiyama, A. See Goto, Shinichiro Hashimoto, M. Eizawa, H. See Yamada, M. See Hiki, K. Hata, T., Itoh, E. and Kawabata, A. Epand, R.M. Serotonin in stressed rats 101 See Nakamuta, H. Hata, T., Kawabata, A. and Itoh, E. Etoh, S., Baba, A. and Iwata, H. SART stress and hemostatic system 403 Hatakeyama, K., Yano, S. and Watanabe, K. See Morishita, S. PAF and gastric lesions 271 Ito, M. Hatta, S., Amemiya, N. and Ohshika, H. See Hattori, T. Galactosamine and adenylate cyclase activity 385 Re, Y. Hattori, R. See Iwanaga, Y. See Hiki, K. Itoh, E. Hattori, T., Ito, M. and Suzuki, Y. See Hata, T. Effect of TJ-8014 on PAN-nephrosis 465 Itoh, Z. Hibi, M. See Iwanaga, Y. See Yamamoto, A. Itokazu, Y. Hiki, K., Yui, Y., Hattori, R., Eizawa, H., See Nakamuta, H. Kosuga, K. and Kawai, C. Iwama, T. Cytosolic and membrane-bound NO synthase 217 See Yamamoto, A. Hironaka, M. Iwamoto, M. See Togari, A. See Kurahashi, K. Hisajima, H., Miyagawa, T., Saito, H. Iwanaga, Y., Miyashita, N., Mizutani, F., and Nishiyama, N. Morikawa, K., Kato, Hideo, Ito, Y. and Itoh, Z. Neurotrophic effects of human aFGF 495 HSR-803 on gastrointestinal propulsion 261 Hombhanje, F. Iwasaki, K. Sulphadimidine dosage on acetylator phenotyping See Nakazawa, M. 531 Iwata, H. See Etoh, S. Ichida, S., Ariyoshi, S., Fujisue, T., Wada, T. and Akimoto, T. Jiang, H. Effects of calcium agonists on rat uterus 397 See Nakadate, T. Imai, S. See Nakazawa, M. Kaburagi, T. Imai, Y. See Shimizu, K. See Yonehara, N. Kajiyama, H. Inaba, N., Inazu, N., Kogo, H. and Satoh, Tetsuo See Fujimura, A. Antiestrogen and aldo-keto reductase 61 Kamegaya, Y. Inami, K. See Nakadate, T. See Yoshida, Y. Kamei, J., Tanihara, H. and Kasuya, Y. Inazu, N. Antitussive tolerance and x-opioid receptors 557 See Inaba, N. Kamei, K., Tsuchida, S., Taguchi, K. Inoki, R. and Nishikibe, M. See Yonehara, N. Effect of NB-818 on neuronal death 279 Inoue, O. Kaneto, H. See Takase, H. See Takahashi, M. in, Y. Kashima, K. See Abe, K. See Kato, M. Ishihara, M. Kasuya, Y. See Nakadate, T. See Kamei, J. Ishihara, T. Kataoka, K. See Aisaka, K. See Kato, M. Ishikawa, M., Takayanagi, Y. and Sasaki, K. Kato, Hideo Exacerbation of DOX toxicity by CPZ 221 See Iwanaga, Y. Ishikawa, N. Kato, Hitoshi See Sakakibara, H. See Takata, Y. Ishitani, R. Kato, M., Ohkuma, S., Kataoka, K., Kashima, K., See Saito, M. Mukainaka, T. and Kuriyama, K. Ito, Hiroko Amylase release from pancreatic acini 311 See Ito, Hitoshi Kato, R. Ito, Hitoshi, Ito, Hiroko, Amano, H. and Noda, H. See Nakadate, T. Antitumor effect of cepharanthin 195 Kawabata, A. Ito, C. See Hata, T. Kawaguchi, A. Kusama, T., Murakoshi, Y. and Murakami, H. See Kurahashi, K. Withdrawal response of hippocampal slices 213 Kawaguchi, M. See Sawaki, K. Maggi, C.A. Kawai, C. See Evangelista, S. See Hiki, K. Mano, F. Kawamura, Makoto, Yamazaki, S., Tobe, A., See Tsuchihashi, H. Watanabe, S. and Takeuchi, T. Maruyama, K. Effects of MCI-727 on plasma secretin 513 See Tsuchihashi, H. Kawamura, Masahiro, Matsui, T., Niitsu, A., Masuda, Y. and Yamamori, Y. Kondo, T., Ohno, Y. and Nakamichi, N. CBrCl3 hepatotoxicity in isolated livers 143 Purinoceptor in adrenocortical cell 543 Histology of lipid peroxidation 133 Kawanishi, M. Matsui, T. See Sakakibara, H. See Kawamura, Masahiro Kimura, I. Matsumoto, K. See Naitoh, T. See Ohta, H. See Nojima, H. Matsumoto, S. Kimura, M. See Togari, A. See Naitoh, T. Mihara, S. and Fujimoto, M. See Nojima, H. Effect of S-312 on 1,4-DHP binding sites 249 Kimura, Y. Mitani, A. See Ebii, K. See Aisaka, K. Kinatni, J. Miyagawa, T. See Tsuchihashi, H. See Hisajima, H. Kitagaki, K. Miyashita, N. See Nagai, H. See Iwanaga, Y. Kitajima, Y. Mizutani, F. See’ Aisaka, K. See Iwanaga, Y. Kitamura, Y., Ohnuki, T. and Nomura, Y. Mori, H. Bifemelane on mACh-R in SAM brain 231 See Yoshida, Y. Kiuchi, Y. Mori, J. See Yamada, M. See Takakura, S. Kobayashi, S. Morikawa, K. See Naitoh, T. See Iwanaga, Y. Koda, A. Morisaki, N. See Nagai, H. See Saeki, T. See Yoshida, Y. Morishita, S., Shoji, M., Oguni, Y., Ito, C., Kogo, H. Noguchi, K. and Sakanashi, M. See Inaba, N. Experimental congestive heart failure 427 Koida, M. Motomura, S. See Nakamuta, H. See Sugiyama, A. Koike, K. Mukainaka, T. See Takayanagi, I. See Kato, M. Kondo, T. Murakami, H. See Kawamura, Masahiro See Kusama, T. Kosuga, K. Murakoshi, Y. See Hiki, K. See Kusama, T. Krieglstein, J. See Rischke, R. Nagai, H., Kitagaki, K., Goto, Shoichi, Suda, H. Kurahashi, K., Usui, H., Iwamoto, M., Aoki, S., and Koda, A. Kawaguchi, A. and Oikawa, H. K* channel opener and allergic reaction 13 Artery reinnervated by cholinergic fiber 117 Nagata, M. and Osumi, Y. Kuribara, H., Asashi, T. and Tadokoro, S. Nicotine and gastric motility 539 Interaction between opioids and ethanol 457 Nagatomo, T. Kuriyama, K. See Tsuchihashi, H. See Kato, M. Naitoh, T., Kobayashi, S., Kimura, I. and Kimura, M. See Takayanagi, I. [Ca?*];-regulated glucose uptake by insulin 241 Oikawa, H. Nakadate, T., Yamamoto, S., Kamegaya, Y., See Kurahashi, K. Ishihara, M., Aizu, E., Jiang, H. and Kato, R. Orlowski, R.C. ODC induction and protein kinase C 203 See Nakamuta, H. Nakajyo, S. Osumi, Y. See Shimizu, K. See Nagata, M. Nakamichi, N. Ouchi, K. See Kawamura, Masahiro See Sawaki, K. Nakamuta, H., Itokazu, Y., Koida, M., Ozawa, J. Orlowski, R.C. and Epand, R.M. See Takata, Y. hCT sensitive binding sites 551 Nakayama, S. Rischke, R. and Krieglstein, J. See Ebii, K. Neuroprotective effects of vinpocetine 349 Nakazawa, M., Sawanobori, T., Iwasaki, K. and Imai, S. Saegusa, K., Furukawa, Y., Akahane, K.., Benazeprilat and acute heart failure 369 Haniuda, M. and Chiba, S. Ni, X.-H. Eperisone on the heart 187 See Ohta, H. Saeki, T., Ohtsuka, I., Hashida, R., Shiojiri, H., Niitsu, A. Yamatsu, I., Morisaki, N. and Saito, Yasushi See Kawamura, Masahiro Antiatheromatous effect of E5050 159 Nishikibe, M. Saito, H. See Kamei, K. See Abe, K. Nishiyama, N. See Hisajima, H. See Hisajima, H. Saito, K. Noda, H. See Takayanagi, I. See Ito, Hitoshi Saito, M., Serikyaku, S. and Ishitani, R. Noguchi, K. Lipids in tryptamine binding sites 413 See Morishita, S. Saito, Yasushi Nojima, H., Kimura, I. and Kimura, M. See Saeki, T. Ca**-dependence of ACh-contractures 109 Saito, Yuji Nomura, Y. See Takase, H. See Kitamura, Y. Saitoh, Yuichi See Ebii, K. Oguchi, K. Sakakibara, H., Taki, K., Kawanishi, M., See Yamada, M. Shimada, Y. and Ishikawa, N. Oguni, Y. Lung vascular permeability 391 See Morishita, S. Sakanashi, M. Ohashi, K. See Morishita, S. See Fujimura, A. Sakashita, M. Ohkuma, S. See Yamamoto, A. See Kato, M. Sasaki, K. Ohno, T. See Ishikawa, M. See Aisaka, K. Sato, Toshihiro Ohno, Y. See Sawaki, K. See Kawamura, Masahiro Satoh, H. Ohnuki, T. See Takakura, S. See Kitamura, Y. Satoh, M. Ohshika, H. See Takayanagi, I. See Hatta, S. Satoh, Tetsuo Ohta, H., Ni, X.-H., Matsumoto, K. See Inaba, N. and Watanabe, H. Sawaki, K., Ouchi, K., Sato, Toshihiro Physostigmine and working memory in rats 303 and Kawaguchi, M. Ohtsuka, I. Local anesthetic convulsions and GABA 327 See Saeki, T. Sawanobori, T. Ohtsuki, H. See Nakazawa, M. Serikyaku, S. and Satoh, M. See Saito, M. PrBCM-sensitive cholinoceptors 151 Shiga, T. Takayanagi, M. See Fujimura, A. See Abe, K. Shiino, A. Takayanagi, Y. See Takakura, S. See Ishikawa, M. Shikada, K. Takeuchi, T. See Yamamoto, A. See Kawamura, Makoto Shimada, A. and Yanagita, T. Taki, K. Barbital tolerance and physical dependence 71 See Sakakibara, H. Shimada, Y. Tanaka, Sakuya See Sakakibara, H. See Yamamoto, A. Shimizu, K., Kaburagi, T., Nakajyo, S. Tanaka, Shoukichi and Urakawa, N. See Yoshimura, Y. Muscle tension and glucose utility 53 Taniguchi, T. Shinoda, H. See Ebii, K. See Togari, A. Tanihara, H. Shiojiri, H. See Kamei, J. See Saeki, T. Tobe, A. Shoji, M. See Kawamura, Makoto See Morishita, S. Togari, A., Arai, M., Hironaka, M., Matsumoto, S. Silva, W.I. and Shinoda, H. G, and Gg subunits in coated vesicles 97 HEBP on experimental osteoporosis 177 G, subunits in coated vesicles 93 Tsuchida, S. Suda, H. See Kamei, K. See Nagai, H. Tsuchihashi, H., Maruyama, K., Baba, S., Mano, F., Sugiyama, A., Motomura, S. and Hashimoto, K. Kinami, J. and Nagatomo, T. Cardiovascular effects of NIK-244 1 a,-Adrenoceptor subtypes 523 Susumu, T. Tsujimoto, A. See Takakura, S. See Yoshimura, Y. Suzuki, A. See Takase, H. Uchida, M., Yano, S. and Watanabe, K. Suzuki, Y. Gastric antral ulcer in rats 475 See Hattori, T. Urakawa, N. See Shimizu, K. Tadokoro, S. Ushio, Y. and Abe, H. See Kuribara, H. Increase in yeast phagocytosis by saikosaponin-d Taguchi, K. 167 See Kamei, K. Usui, H. Takada, K. See Kurahashi, K. See Yoshimura, Y. Takahashi, M. and Kaneto, H. Wada, T. Stresses and spinal morphine tolerance 121 See Ichida, S. Takakura, S., Susumu, T., Satoh, H., Mori, J., Watanabe, H. Shiino, A. and Handa, J. See Ohta, H. Brain protection with nilvadipine 547 Watanabe, K. Takase, H., Inoue, O., Saito, Yuji, Yumioka, E. See Hatakeyama, K. and Suzuki, A. See Uchida, M. Protective property of Oren-gedoku-to 433 Watanabe, S. Takata, Y., Ozawa, J. and Kato, Hitoshi See Kawamura, Makoto NE release and low Ca?* + TEA medium 535 Protein kinase C and norepinephrine release 337 Yamada, K. Takayanagi, I., Harada, M. and Koike, K. See Yoshimoto, R. PrBCM-sensitive and -resistant muscarinic receptors Yamada, M., Kiuchi, Y., Hashimoto, M., Oguchi, K. 23 and Yasuhara, H. Takayanagi, I., Ohtsuki, H., Saito, K., Koike, K. PEA treated rats after withdrawal 127 Yamamori, Y. See Uchida, M. See Masuda, Y. Yasuhara, H. Yamamoto, A., Shikada, K., Iwama, T., See Yamada, M. Sakashita, M., Hibi, M. and Tanaka, Sakuya Yonehara, N., Imai, Y. and Inoki, R. NZ-107 modulates tracheal response 79 Heat stimulation and neuropeptides 381 Yamamoto, S. Yoshida, Y., Mori, H., Inami, K. and Koda, A. See Nakadate, T. Active principle of prostate extract 357, 441 Yamanaka, Y. Yoshimoto, R., Dohmoto, H., Yamada, K. See Goto, Shinichiro and Goto, A. Yamatsu, I. Inhibition of Ca influx by cinaldipine 225 See Saeki, T. Yoshimura, Y., Dohi, T., Tanaka, Shoukichi, Yamazaki, S. Takada, K. and Tsujimoto, A. See Kawamura, Makoto Brain catecholamines and lidocaine convulsions 85 Yanagita, T. Vou x; See Shimada, A. See Hiki, K. Yano, S. Yumioka, E. See Hatakeyama, K. See Takase, H. SUBJECT INDEX A431 cells 203 Ca’?*-dependence 109 Acetylator phenotyping 531 Calcitonin (human) 551 Acidic fibroblast growth factor 495 Calcitonin gene-related peptide 381 Acoustic stimulation 127 Calcitonin receptor subtype 551 Active metabolite 43 Calcium agonists 397 Adenosine 79 Calcium influx 225 Adenylate cyclase 385 Capsaicin 377 ADP-Fe** 133 Cardiac 8-adrenoceptor 505 a,-Adrenoceptors 523 Carteolol 505 Aged rat 43, 303 Castrated rat 441 Aldo-keto reductase 61 Catecholamine 85 Allergic reaction 13 Cell culture 495 Ambulatory activity (mouse) 457 Cell growth 203 y-Aminobutyric acid 327 Cepharanthin 195 Ammonia 475 Cerebellar neuron survival 113 Amylase release 311 Cerebral ischemia 349, 547 Angiotensin converting enzyme inhibitor 369 Cerebrospinal fluid (human) 297 Anti-GBM nephritis 465 Chlorpromazine 221 Anti-prostatic hypertrophy 441 Cholesterol-fed rabbits 159 Anti-ulcer agent 513 Cholinergic partial agonist 151 Antiestrogen 61 Chronopharmacology 43, 105, 237 Antinociception 121 Chronotropism 1 Antitussive effect 557 Clathrin coated vesicles 93, 97 Antral ulcer 475 Compression-type contracture 109 Aortic smooth muscle cells (rat) 249 Contraction 337 Arachidonate metabolism 271 Convulsion 85, 327 Aspirin 475 Coronary embolization 369 Atherosclerosis 159 Cortical evoked potential 71 ATP 543 Cytosolic 217 Atrium (isolated dog) 187 Cytosolic Ca2* 151, 249 Autoradiography 551 Delayed nonmatching to position task 303 Barbital 71 Dentin 177 Basic fibroblast growth factor 113, 563 2-Deoxy-D-glucose 475 Basilar blood vessels (porcine) 249 Depolarization 337 Behavior 127 Diaphragm muscle 241 Benazeprilat 369 Diazepam 457 Bifemelane hydrochloride 231 Digoxin 427 Biogenic amines 33 1,4-Dihydropyridine binding sites 249 Blood coagulation 403 Diuretic effect 237 Blood pressure 245 Dopaminergic system 33 Bone 177 Dorsal motor nucleus of vagus 539 Brain (mouse) 85 Dosage 531 Brain (rat) 523 Doxorubicin (toxicity) 221 Brain amine levels 127 Dromotropism 1 Brain sections 33 Drug effects 483 Bromotrichlomomethane hepatotoxicity 143 Drug interaction 421 Bronchoconstriction 13 t-Butyl hydroperoxide 133 E5050 (N-{3-[4’-(2” ,6’-dimethylheptyl)phenyl]- butanoyl}ethanolamine) 159 “Ca uptake 397 Endogenous substances 297 Ca?* channel 535 Eperisone 187 Ca?* channel blocker 33, 547 Epidermal growth factor 113 Ethanol 457 Lipid peroxidation 133, 143 Euglobulin clot lysis time 403 Lithium 421 Experimental asthma 13 Local anesthetic 327 Experimental congestive heart failure 427 Local cerebral blood flow 349 Loop diuretic 43, 105 Fe receptor 167 Lung metastasis 195 Fibrinogen 403 Lungs 391 Fibrinolysis 403 Luteinizing hormone-releasing hormone (LH-RH) Fibrous plaque 159 61 Flecainide 1 Footshock stress 121 Macrophages 167 FRC-8653 (2-methoxyethyl(E)-3-phenyl-2-propen-1- MCI-727 ((Z)-2-(4-methylpiperazin-1-yl)-1-[4-(2- yl( + )-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)- phenyl-ethyl)phenyl]-ethanone oxime hydrochloride pyridine-3,5-dicarboxylate) 225 monohydrate 513 Fuchsin staining 133 Membrane-bound 217 Full agonist 23 Memory 483 Furosemide 421 N-Methyl-D-aspartate 287 Mineralization 177 Galactosamine 385 Morphine 121 Gastric damage 271 Muscarinic receptor 187, 231, 311 Gastric emptying 261 Gastric motility 539 Na‘ channel 535 Gastric mucosal protection 433 Naloxone 213 Gastric ulcers 377 NB-818 (isopropyl methyl 2-carbamoyloxymethyl-6- Gastrin 513 methyl-4-(2,3-dichlorophenyl)1 ,4-dihydropyridine- Gerbil 279 3,5-dicarboxylate) 279 Glutamic acid 327 Necrosis 143 GTP-binding protein 385 Neurokinin A 381 GTP-binding proteins alpha subunits 93, 97 Neuron 495 GTP-binding proteins beta subunits 97 Neuronal damage 349 Neuronal death 279 Heart failure 369 Neuronal survival 563 HEBP (1-hydroxyethylidene-1 ,1-bisphosphonate) Neurotrophic factor 495 177 N°-monomethyl-L-arginine (L-NMMA) 245 High K* ,Na* -deficient solution 53 Nicotine 539 Hippocampal slice 213 Nicotinic receptor 187 Hippocampus 279, 349 NIK-244 (Ethacizin) (2-(ethoxycarbonylamino)-10-(3- 5-HT uptake 297 (diethylamino)propionyl) phenothiazine hydrochlo- Hydrochloric acid 475 ride) 1 Nilvadipine 547 IgE antibody 13 Nitrendipine 237 Ileum (guinea pig) 53 Nitric oxide 245 Imipramine binding 297 Nitric oxide synthase 217 Implantation 117 Non-matching to sample 483 Inotropism 1 Norepinephrine release 337, 535 Insulin-stimulated glucose uptake 241 NZ-107 (4-bromo-5-(3-ethoxy-4-methoxybenzyl- Intracellular Ca** 241 amino)-3(2H)-pyridazinone) 79 Intrinsic sympathomimetic activity 505 Opioid analgesics 457 Jackknife-type contracture 109 x-Opioid receptors 557 Japanese herbal medicine 465 Oren-gedoku-to (OGT) 433 Ornithine decarboxylase 203 K* channel opener 13 Ovariectomy 177 Ovary (rat) 61 Learning 483 Ovulation 61 Lidocaine 85 Oxidized flavoproteins (FPox) 53 Oxygen consumption 369 Saikosaponin-d 167 Saphenous vein (canine) 337, 535 Pancreatic acini (isolated) 311 Scavengers 465 Pancreatic secretion 513 Secretin 513 Papua New Guineans 531 Senescence-accelerated mouse 231 Paroxetine binding 297 Serotonergic system 33 Partial agonist 23 Serotonin 101 Pentobarbital 457 Single skeletal muscle cell 109 Perfused liver 133, 143 Small intestinal transit 261 Phagocytosis 167 Smooth muscle cell 159 &-Phenylethylamine 127 Spinal cord 327 Phosphatidylserine 413 Spinal tolerance 121 Phospholipase A, 413 Spleen (rat) 523 Physical dependence 71 Spontaneously hypertensive rats 505 Physostigmine 303 Steroidogenesis 543 Platelet activating factor 271 Stress 101, 403 °H-Prazosin 523 Subclassification 523 Preganglionic trunk 117 Substance P 381 Propylbenzilylcholine mustard (PrBCM) 23 Sulfhydryl compounds 433 Propylbenzilylcholine mustard (PrBCM)-resistant Sulphadimidine 531 cholinoceptors 23, 151 Sympathetic nerve stimulation 391 Propylbenzilylcholine mustard (PrBCM)-sensitive Synaptoneurosome 287 cholinoceptors 23, 151 Prostaglandin 79, 271 Temperature-sensitive high-affinity binding sites 413 Prostate extract 357, 441 Tension 53 Prostate extract (purified) 357, 441 Tension development 151 Prostatic hypertrophy 357 Testosterone 441 Protein kinase 563 Testosterone uptake 357 Protein kinase C 203, 287, 337 Toad venom 427 Psychological stress 121 Tolerance 71, 557 Purinoceptor 543 Tracheal response 79 Puromycin aminonucleoside (PAN) 465 Translocation 287 Pyridine nucleotides (PNred) 53 Tryptamine 413 Tubular secretion 421 Reactive oxygen species 465 Rebound phenomena 505 Uterine segments (rat) 397 Reinnervation 117 Repeated cold stress 101 Vascular permeability 271, 391 Retina 495 Vinpocetine 349 Reverse tolerance 127 Water-immersion stress 377 S-312 (methyl 4,7-dihydro-3-isobutyl-6-methyl-4-(3- Withdrawal response 213 nitrophenyl)thieno[2,3-b]pyridine-5-carb oxylate) Working memory 303 249 S-8666 (6,7-dichloro-5-(N ,N-dimethylsulfamoyl)-2,3- Yeasts 167 dihydro-2-benzofuran carboxylic acid) 43, 105